X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4203) 4203
Magazine Article (23) 23
Newspaper Article (18) 18
Newsletter (10) 10
Book Chapter (6) 6
Web Resource (3) 3
Book Review (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3781) 3781
female (2489) 2489
adult (1425) 1425
lupus erythematosus, systemic - chemically induced (1405) 1405
male (1405) 1405
middle aged (1237) 1237
index medicus (1198) 1198
lupus erythematosus, systemic - drug therapy (982) 982
rheumatology (830) 830
systemic lupus erythematosus (801) 801
animals (761) 761
lupus (707) 707
aged (658) 658
systemic-lupus-erythematosus (651) 651
lupus erythematosus, systemic - immunology (588) 588
lupus erythematosus, systemic - complications (517) 517
mice (470) 470
adolescent (436) 436
immunology (392) 392
risk factors (335) 335
therapy (322) 322
autoimmunity (305) 305
rheumatoid-arthritis (291) 291
medicine, general & internal (281) 281
antirheumatic agents - adverse effects (277) 277
autoimmune diseases (274) 274
lupus erythematosus, systemic - diagnosis (274) 274
arthritis, rheumatoid - drug therapy (266) 266
immunosuppressive agents - adverse effects (261) 261
procainamide - adverse effects (258) 258
autoantibodies (255) 255
dermatology (249) 249
disease (237) 237
erythematosus (235) 235
time factors (232) 232
disease models, animal (231) 231
systemic lupus-erythematosus (227) 227
treatment outcome (214) 214
hydralazine - adverse effects (213) 213
lupus erythematosus, systemic - pathology (208) 208
antibodies (207) 207
antibodies, antinuclear - analysis (206) 206
child (200) 200
diagnosis, differential (190) 190
glucocorticoids - adverse effects (181) 181
immunosuppressive agents - therapeutic use (176) 176
retrospective studies (176) 176
rheumatoid arthritis (175) 175
medicine & public health (170) 170
pharmacology & pharmacy (169) 169
arthritis (166) 166
cyclophosphamide - adverse effects (165) 165
hydroxychloroquine - adverse effects (164) 164
inflammation (163) 163
pregnancy (157) 157
autoimmune diseases - chemically induced (152) 152
young adult (151) 151
adrenal cortex hormones - adverse effects (150) 150
research (149) 149
research article (148) 148
care and treatment (146) 146
follow-up studies (146) 146
abridged index medicus (144) 144
analysis (137) 137
autoimmune diseases - immunology (137) 137
lupus erythematosus, cutaneous - chemically induced (135) 135
drug therapy (133) 133
dose-response relationship, drug (130) 130
hydroxychloroquine (127) 127
lupus erythematosus, systemic - genetics (125) 125
risk (125) 125
autoantibodies - immunology (123) 123
lupus erythematosus, systemic - blood (122) 122
prednisone - therapeutic use (122) 122
proteins (121) 121
health aspects (120) 120
apoptosis (119) 119
patients (118) 118
antibodies, monoclonal - adverse effects (113) 113
biopsy (113) 113
corticosteroids (113) 113
mice, inbred c57bl (112) 112
retinal diseases - chemically induced (112) 112
syndrome (111) 111
antirheumatic agents - therapeutic use (110) 110
cytokines (108) 108
nephritis (107) 107
drug eruptions - etiology (106) 106
chloroquine - adverse effects (105) 105
complications and side effects (105) 105
cyclophosphamide - therapeutic use (104) 104
drug-induced lupus (104) 104
pathogenesis (104) 104
infliximab (103) 103
sle (103) 103
anti-bacterial agents - adverse effects (101) 101
drug therapy, combination (101) 101
lupus erythematosus, systemic - physiopathology (99) 99
neutrophils (97) 97
hydroxychloroquine - therapeutic use (96) 96
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3782) 3782
French (155) 155
German (113) 113
Japanese (44) 44
Spanish (42) 42
Polish (26) 26
Russian (26) 26
Italian (20) 20
Hebrew (14) 14
Chinese (13) 13
Dutch (10) 10
Portuguese (10) 10
Swedish (7) 7
Danish (6) 6
Finnish (5) 5
Hungarian (5) 5
Norwegian (5) 5
Romanian (3) 3
Croatian (2) 2
Czech (2) 2
Serbian (2) 2
Icelandic (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drug Safety, ISSN 0114-5916, 5/2011, Volume 34, Issue 5, pp. 357 - 374
Journal Article
JAMA dermatology (Chicago, Ill.), ISSN 2168-6068, 08/2013, Volume 149, Issue 8, pp. 935 - 940
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation of the offending drug... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | RHEUMATOID-ARTHRITIS | AUTOANTIBODIES | ANTINUCLEAR | NECROSIS-FACTOR-ALPHA | INDUCTION | DERMATOLOGY | Anti-TNF alpha-induced lupus | THERAPY | INFLIXIMAB | ASSOCIATION | EPIDEMIOLOGY | PSORIASIS | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 01/2017, Volume 56, Issue 1, pp. 121 - 128
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2017, Volume 76, Issue 3, pp. 534 - 542
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0166270
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease and despite the improvement in the survival in the past few decades, the morbidity due to disease damage remains significant... 
SURVIVAL | HYDROXYCHLOROQUINE | PREDICTORS | MULTIDISCIPLINARY SCIENCES | INCEPTION COHORT | ORGAN DAMAGE | COLLABORATING-CLINICS/AMERICAN-COLLEGE | DISEASE EXPRESSION | ETHNIC-GROUPS | INDEX | ASSOCIATION | Severity of Illness Index | Osteoporosis - chemically induced | Lupus Erythematosus, Systemic - epidemiology | Humans | Middle Aged | Risk Factors | Male | Adrenal Cortex Hormones - therapeutic use | India | Adrenal Cortex Hormones - adverse effects | Asian Continental Ancestry Group | Ethnic Groups | Diabetes Mellitus - physiopathology | China | Diabetes Mellitus - epidemiology | Lupus Erythematosus, Systemic - drug therapy | Malaysia - epidemiology | Adult | Diabetes Mellitus - chemically induced | Female | Lupus Erythematosus, Systemic - physiopathology | Osteoporosis - physiopathology | Cohort Studies | Osteoporosis - epidemiology | Lupus | Medical research | Osteoporosis | Corticosteroids | Systemic lupus erythematosus | Medical centers | Analysis | Medicine, Experimental | Development and progression | Diabetes | Corticoids | Demography | Neuropsychiatry | Medical records | Arthritis | Malignancy | Demographics | Biomedical materials | Biocompatibility | Prednisolone | Damage assessment | Immunoglobulins | Clinics | Internal medicine | Mortality | Diabetes mellitus | Rheumatology | Regression analysis | Health care facilities | Minority & ethnic groups | Patients | Ethnic factors | Morbidity | Quality of life | Damage patterns | Medicine | Studies | Chronic conditions | Ethnicity | Hospitals | Hydroxychloroquine | Medical prognosis | Autoimmune diseases | Antiphospholipid syndrome
Journal Article
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 08/2015, Volume 17, Issue 1, p. 215
Journal Article